2026 Global: Connected Drug Delivery Devices Market-Competitive Review (2032) report
Description
The 2026 Global: Connected Drug Delivery Devices Market-Competitive Review (2032) report features the global market size and projected growth/decline data for the period 2021 and 2032. The report primarily provides an examination of the business strategies for the ten largest global companies in the market and how their strategies differ.
Leading players in the Connected Drug Delivery Devices Market include Novo Nordisk A/S, Sanofi S.A., Eli Lilly and Company, and Medtronic plc, each contributing through device-enabled therapeutics and data integration. Novo Nordisk A/S — Bagsværd, Denmark — has integrated smart delivery pens and adherence platforms, leveraging connected devices to track dosing, timing, and patient outcomes across programs. Sanofi S.A. — Paris, France — combines auto-injectors and insulin pens with cloud platforms, improving treatment continuity. Eli Lilly and Company — Indianapolis, United States — emphasizes smart pens and connected autoinjectors alongside patient support ecosystems, enabling real-time dose tracking and coaching. Medtronic plc — Dublin, Ireland — brings infusion pumps and associated software to the connected delivery space, enabling remote monitoring, telemetry, and integration with electronic medical records. Together, these incumbents set interoperability standards and drive adoption among clinicians and patients worldwide today. These collaborations advance patient outcomes and stimulate global innovation.
Insulet Corporation — Acton, United States — and Tandem Diabetes Care, Inc. — San Diego, United States — illustrate insulin delivery ecosystems with networked devices synchronizing dosing. Insulet’s Omnipod System uses wireless data transmission to caregiver portals and apps, enabling dose logging and titration. Tandem Diabetes Care’s t:slim X2 pump uses cellular and Bluetooth connectivity to share glucose trends and pump status with clinicians. Becton, Dickinson and Company (BD) — Franklin Lakes, United States — provides auto-injector platforms and subcutaneous delivery components increasingly equipped with telemetry for remote monitoring. West Pharmaceutical Services — Exton, United States — focuses on primary packaging and connected delivery solutions, including sensor-enabled caps that track usage. AptarGroup, Inc. — Cranbury, United States — offers actuation devices integrated with digital health platforms for remote adherence. Terumo Corporation — Tokyo, Japan — develops infusion and injection devices with wireless connectivity to support hospital and home-based treatment workflows.
Across regions, these players are accelerating connected drug delivery through collaboration with providers, payers, and patients. The convergence of smart devices, cloud-based analytics, and secure data exchange is reshaping adherence programs, precision dosing, and remote monitoring, while meeting stringent privacy and safety requirements. Regulatory frameworks across the United States, Europe, and Asia increasingly support interoperability standards, security certifications, and real-time telemetry, enabling multi-vendor integration. The leading companies invest in module-level standardization, open application programming interfaces, and scalable manufacturing to support device ecosystems embedded in clinics and home-care settings. Market growth is driven by rising chronic disease prevalence, demand for remote care, and the need to reduce medical errors and hospital visits. As developers address affordability and accessibility, partnerships with systems and digital health platforms will be essential for scale. Collectively, the firms described here illustrate a dynamic market where connectivity, data governance, and patient engagement determine competitive advantage for all.
Leading players in the Connected Drug Delivery Devices Market include Novo Nordisk A/S, Sanofi S.A., Eli Lilly and Company, and Medtronic plc, each contributing through device-enabled therapeutics and data integration. Novo Nordisk A/S — Bagsværd, Denmark — has integrated smart delivery pens and adherence platforms, leveraging connected devices to track dosing, timing, and patient outcomes across programs. Sanofi S.A. — Paris, France — combines auto-injectors and insulin pens with cloud platforms, improving treatment continuity. Eli Lilly and Company — Indianapolis, United States — emphasizes smart pens and connected autoinjectors alongside patient support ecosystems, enabling real-time dose tracking and coaching. Medtronic plc — Dublin, Ireland — brings infusion pumps and associated software to the connected delivery space, enabling remote monitoring, telemetry, and integration with electronic medical records. Together, these incumbents set interoperability standards and drive adoption among clinicians and patients worldwide today. These collaborations advance patient outcomes and stimulate global innovation.
Insulet Corporation — Acton, United States — and Tandem Diabetes Care, Inc. — San Diego, United States — illustrate insulin delivery ecosystems with networked devices synchronizing dosing. Insulet’s Omnipod System uses wireless data transmission to caregiver portals and apps, enabling dose logging and titration. Tandem Diabetes Care’s t:slim X2 pump uses cellular and Bluetooth connectivity to share glucose trends and pump status with clinicians. Becton, Dickinson and Company (BD) — Franklin Lakes, United States — provides auto-injector platforms and subcutaneous delivery components increasingly equipped with telemetry for remote monitoring. West Pharmaceutical Services — Exton, United States — focuses on primary packaging and connected delivery solutions, including sensor-enabled caps that track usage. AptarGroup, Inc. — Cranbury, United States — offers actuation devices integrated with digital health platforms for remote adherence. Terumo Corporation — Tokyo, Japan — develops infusion and injection devices with wireless connectivity to support hospital and home-based treatment workflows.
Across regions, these players are accelerating connected drug delivery through collaboration with providers, payers, and patients. The convergence of smart devices, cloud-based analytics, and secure data exchange is reshaping adherence programs, precision dosing, and remote monitoring, while meeting stringent privacy and safety requirements. Regulatory frameworks across the United States, Europe, and Asia increasingly support interoperability standards, security certifications, and real-time telemetry, enabling multi-vendor integration. The leading companies invest in module-level standardization, open application programming interfaces, and scalable manufacturing to support device ecosystems embedded in clinics and home-care settings. Market growth is driven by rising chronic disease prevalence, demand for remote care, and the need to reduce medical errors and hospital visits. As developers address affordability and accessibility, partnerships with systems and digital health platforms will be essential for scale. Collectively, the firms described here illustrate a dynamic market where connectivity, data governance, and patient engagement determine competitive advantage for all.
Table of Contents
32 Pages
- 1.0 Scope of Report and Methodology
- 2.0 Market SWOT Analysis and Players
- 2.1 Market Definition
- 2.2 Market Segments
- 2.3 Market Strengths
- 2.4 Market Weaknesses
- 2.5 Market Threats
- 2.6 Market Opportunities
- 2.7 Major Players
- 3.0 Competitive Analysis
- 3.1 Market Player 1
- 3.2 Market Player 2
- 3.3 Market Player 3
- 3.4 Market Player 4
- 3.5 Market Player 5
- 3.6 Market Player 6
- 3.7 Market Player 7
- 3.8 Market Player 8
- 3.9 Market Player 9
- 3.10 Market Player 10
- 4.0 Comparative Business Strategies
- 4.1 Comparative Business Strategies of Player 1 and 2
- 4.2 Comparative Business Strategies of Player 1 and 3
- 4.3 Comparative Business Strategies of Player 1 and 4
- 4.4 Comparative Business Strategies of Player 2 and 3
- 4.5 Comparative Business Strategies of Player 2 and 4
- 4.6 Comparative Business Strategies of Player 3 and 4
- 5.0 Appendix
Search Inside Report
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
